Recently, the Food and Drug Administration of the Ministry of Health and Welfare of Taiwan (FDA) released a report about a new class of hypoglycemic drugs, Glucagon-like peptide-1 (GLP-1) receptor agonists, suspected of causing acute pancreatitis. Wang Chih-yuan, researcher and chairman of the Taiwanese Association of Diabetes Educators, said that patients who use GLP-1 receptor…